HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Nephrology17 papers

Adenosarcoma

Last edited: 4/15/2026

Overview

Adenosarcoma is a rare uterine malignancy characterized by malignant epithelial and mesenchymal elements, often arising in the uterine corpus but can occur in the cervix. A rhabdomyosarcomatous variant exists, which does not inherently indicate a more aggressive behavior compared to typical adenosarcomas 1.

Diagnosis

  • Histopathological Examination: Essential for diagnosis, distinguishing adenosarcoma from other sarcomas like embryonal rhabdomyosarcoma and malignant mixed müllerian tumor 1.
  • Immunohistochemistry: Utilized to differentiate cellular components and confirm the presence of both epithelial and mesenchymal features 1.
  • Imaging: MRI and ultrasound are crucial for staging and assessing tumor extent 1.
  • Grading: Based on mitotic activity and cellular atypia, typically using systems adapted from endometrial stromal sarcomas 1.

    • Management

  • Surgical Excision: Primary treatment, often involving hysterectomy with or without adnexal removal, depending on tumor stage and extent 1.
  • Adjuvant Therapy: Not routinely recommended for low-grade adenosarcomas; high-grade cases may consider adjuvant chemotherapy or radiation, though specific regimens are not detailed in the abstract 1.
  • Close Follow-Up: Essential post-surgery to monitor for recurrence, especially in high-grade cases 1.

    • Special Populations

  • Pregnancy: No specific guidance provided in the abstract regarding management during pregnancy 1.
  • Elderly Patients: Considerations for surgical risk and tolerance to adjuvant therapies are crucial but not explicitly detailed 1.
  • Comorbidities: Management should account for patient comorbidities, influencing surgical approach and adjuvant therapy decisions 1.

    • Key Recommendations

  • Differentiate rhabdomyosarcomatous adenosarcoma from other sarcomas to guide appropriate management (Evidence: Expert opinion) 1.
  • Employ surgical excision as the primary treatment modality for adenosarcoma (Evidence: Expert opinion) 1.
  • Consider close follow-up protocols post-surgery, particularly for high-grade tumors, to monitor for recurrence (Evidence: Expert opinion) 1.

    • References

    1 Chen KT. Rhabdomyosarcomatous uterine adenosarcoma. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1985. link

    Original source

    1. [1]
      Rhabdomyosarcomatous uterine adenosarcoma. — Chen KT International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists (1985)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG